Bolt Biotherapeutics, Inc. (BOLT)
6.00
+0.14
(+2.39%)
USD |
NASDAQ |
Dec 12, 12:44
Bolt Biotherapeutics EPS Diluted (Quarterly): -3.722 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | -0.1144 |
| Protagonist Therapeutics, Inc. | -0.6169 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.144M |
| Revenue (Quarterly) | 2.169M |
| Total Expenses (Quarterly) | 9.313M |
| Enterprise Value | 2.129M |
| Gross Profit Margin (Quarterly) | 86.63% |
| Profit Margin (Quarterly) | -329.4% |
| Earnings Yield | -280.0% |
| Normalized Earnings Yield | -272.39 |